| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.01 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |